Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

D&P Biotech

D&P Biotech
2006 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Developer of molecular diagnostics DNA biomarkers designed to provide customized medicine. The company's molecular diagnostics DNA biomarkers are effective and helps to detect and manage lung cancer, enabling patients to begin the treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Sanglim Building 304
  • 18, Seocho-daero 49-gil, Seocho-gu
  • Seoul, Yeongdeungpo-gu 150-870
  • South Korea

+82 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore D&P Biotech’s full profile, request a free trial.

D&P Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jul-2010 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

D&P Biotech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Korea-Seoul Life Science Fund Venture Capital Minority 000 0000 000000 0
Korea Technology Finance Government Minority 000 0000 000000 0